Last viewed: ELEV


Prices are updated after-hours



Elevation Oncology Inc

ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-11.6% 1m) (120.1% 1y) (0.0% 2d) (0.0% 3d) (1.0% 7d) (-49.46% volume)
Earnings Calendar: 2022-11-04
Market Cap: $ 208,713,283

https://elevationoncology.com
Sec Filling | Patents | 8 employees


Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. The company makes genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. Together with its peers Elevation Oncology works towards a future in which each unique test result can be matched with a purpose-built precision medicine to enable an individualized treatment plan for each patient. Its lead candidate, seribantumab, inhibits tumor growth driven by NRG1 fusions and is currently being clinically tested in the Phase 2 CRESTONE study for patients with tumors of any origin that have an NRG1 fusion. Details on CRESTONE are available at www.NRG1fusion.com.

treatment   cancer  

add to watch list Paper trade email alert is off

Press-releases


Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Published: 2024-04-09 (Crawled : 01:00) - elevationoncology.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.85% H: 1.5% C: 0.64%

preclinical for meeting program
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 23:00) - biospace.com/
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -3.87% H: 0.0% C: 0.0%

preclinical for meeting program
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
Published: 2024-03-06 (Crawled : 12:30) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.71% H: 2.95% C: -1.68%

business year financial results
Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-03-05 (Crawled : 22:00) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.71% H: 2.95% C: -1.68%

association cancer research preclinical meeting program
Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors
Published: 2024-03-04 (Crawled : 12:30) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.4% H: 1.39% C: -4.37%

leaders
Elevation Oncology to Participate in Upcoming Investor Conferences
Published: 2024-02-28 (Crawled : 12:30) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.27% H: 6.76% C: 4.05%


Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan
Published: 2024-02-22 (Crawled : 12:30) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -1.44% H: 5.49% C: -1.1%

eo-3021 first japan ongoing trial
Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
Published: 2024-01-22 (Crawled : 12:30) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -3.16% H: 21.22% C: 15.1%


Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
Published: 2024-01-05 (Crawled : 12:30) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 11.54% H: 43.94% C: 32.52%

program
Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference
Published: 2023-11-22 (Crawled : 12:30) - prnewswire.com
ELEV | $4.29 5.93% 5.59% 330K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.64% H: 4.49% C: -3.51%

conference
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0001415889-24-006289 4 2024-03-04 2024-02-29 Buy A 55000 55000


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
79% 21%

Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 870K twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Last 48 Hours Insiders Buying
RELL P 2500 | $10.335 2.13% 2.08% 98K twitter stocktwits trandingview |
Electronic Technology
| 20:01
TGEN P 6000 | $0.6897 39.71% 2.3K twitter stocktwits trandingview |
Utilities
| 18:30
CMTV P 700 | $15.74 17.43% 12K twitter stocktwits trandingview |
Finance and Insurance
| 18:30
FNB | $13.63 2.17% 0.0% 2.5M twitter stocktwits trandingview |
Finance
| 17:30
HNVR | $16.76 2.51% 2.45% 3.5K twitter stocktwits trandingview |
| 16:30
VUZI P 34500 | $1.315 -2.59% -2.66% 690K twitter stocktwits trandingview |
Electronic Technology
| 16:00
TPL P 3 | $587.81 0.34% -0.39% 41K twitter stocktwits trandingview |
Miscellaneous
| 15:00
ETST P 79000 | $0.065 -67.14% 110K twitter stocktwits trandingview |
Manufacturing
| 11:30
MCFT P 26039 | $21.06 -2.05% -2.09% 130K twitter stocktwits trandingview |
Consumer Durables
| 00:00
YORW P 29 | $35.625 0.58% 0.58% 56K twitter stocktwits trandingview |
Utilities
| 19:01
BANF P 256 | $92.29 1.11% 1.09% 92K twitter stocktwits trandingview |
Finance
| 15:30
RMCF | $3.57 0.28% 2.8K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar